April 24 (Reuters) - GSK plc:
* US FDA ACCEPTS NEW INDICATION FILING FOR JEMPERLI
* 23 AUGUST 2024 ASSIGNED AS PRESCRIPTION DRUG USER FEE ACT ACTION DATE FOR FDA DECISION Source text for Eikon: Further company coverage:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,780 GBX | +0.39% | +4.43% | +22.78% |
May. 08 | Gsk plc Announces Board Committee Changes | CI |
May. 08 | GSK : Receives a Buy rating from Bernstein | ZD |
April 24 (Reuters) - GSK plc:
* US FDA ACCEPTS NEW INDICATION FILING FOR JEMPERLI
* 23 AUGUST 2024 ASSIGNED AS PRESCRIPTION DRUG USER FEE ACT ACTION DATE FOR FDA DECISION Source text for Eikon: Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+22.78% | 90.35B | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |